Dr Susan Elizabeth Foden
Dr Susan Elizabeth Foden was appointed in a total of 31 companies and resigned from 27 of these appointments.
Roles
Director • Secretary
Country Of Residence
Scotland
Nationality
British
Date of Birth
April 1953
Occupations
Company Director • Non-executive Director • Retired • None • Consultant • Non Executive • Investment Director • Self Employed • Unreported • Chief Executive • Manageing Director • Managing Director
Active
2
Resigned
27
Dissolved
2
Other
0
Total
31
Companies
| Company | Timeline | Status | |
| Roslin Foundation Director • Director | 30 Mar 2022←3 Years→Current | Active | |
| Roslin Foundation Director • Director | 30 Mar 2022←2 Years 7 Months→21 Nov 2024 | Active | |
| Neurocentrx Pharma Limited Director • Director | 8 Jun 2021←1 Year 8 Months→5 Feb 2023 | Active | |
| Qbiotics UK Limited Director • Company Director | 3 Jul 2020←5 Years→Current | Active | |
| Qbiotics UK Limited Director • Company Director | 3 Jul 2020←4 Years→2 Nov 2024 | Active | |
| Butterfly Conservation Trading Limited Director • Non-executive Director | 26 Nov 2016←5 Years→29 Nov 2021 | Active | |
| BTG Limited Director • Company Director | 1 Mar 2015←4 Years→19 Aug 2019 | Active | |
| Butterfly Conservation Director • Retired | 17 Nov 2012←8 Years→13 Nov 2021 | Active | |
| Newlands Court Management Company Limited Director • Director | 19 Dec 2011←7 Years→23 Aug 2019 | Active | |
| Theracryf Pharma Ltd Director • Director | 25 Aug 2011←4 Years→21 Oct 2015 | Active | |
Mutual People
- Peter Stephen KeenExcalibur Fund Managers Limited, Cyclacel Limited, Vectura Group Limited, and 2 more are mutual companies.
- Julian Paul ThurstonCancer Research Technology Limited, Kudos Pharmaceuticals Limited, Biovex Limited, and 1 more are mutual companies.
- Roderick Iain WallaceCancer Research Technology Limited, Cyclacel Limited, Kudos Pharmaceuticals Limited, and 1 more are mutual companies.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
